Founder-first early-stage VC (founded 2008) active in both France and the US, with a differentiated neuroscience/mental health thesis. Backed primarily by entrepreneurs and family offices.
Auto-extracted from press releases.
Auto-detected from Newfund's website.
Biotech scientist and innovation analyst at Solvay. Previously financed startups at Bpifrance through loans and guarantees.
Early VC investor since 1999 with exits in CDiscount, Allociné, Direct Energie, and Xilam Animation. Co-founded Newfund in 2008.
Stanford MBA, founded ModeWalk acquired by Moda Operandi. Co-founded StartX accelerator and was VP Strategy there.
Private banking and telecom executive with 9 years at Arkadin managing US operations and M&A in London.
Investment Director supporting business buyouts and SME transformation through AI. 12 years strategy and operations experience at EY and LVMH.
Former CFO/COO in entertainment at Gaumont, Cryo, and Xilam Animation. Co-founded Newfund in 2008.
JPMorgan analyst and Roland Berger consultant focused on tech due diligence. Supported portfolio companies raising $100m+ Series A.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.